Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis

Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis

Purpose: Immunomodulatory agents, including conventional immunosuppressive treatment and biologics, are the mainstay of treating chronic uveitis. Janus kinase ( JAK) inhibitors, one of the newest biologics, have shown successful outcomes in treating autoimmune diseases such as rheumatoid arthritis...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Dominguez, Sawyer Vaclaw, Cynthia McClard, Matlock A. Jeffries, Jila Noori
Format: Article
Language:English
Published: Knowledge E 2025-05-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Birdshot Chorioretinopathy
JAK Inhibitors
Upadacitinib
Uveitis
Online Access:https://knepublishing.com/index.php/JOVR/article/view/14952
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items